...
首页> 外文期刊>International journal of infectious diseases : >The use of bedaquiline to treat patients with multidrug-resistant tuberculosis and end-stage renal disease: A case report
【24h】

The use of bedaquiline to treat patients with multidrug-resistant tuberculosis and end-stage renal disease: A case report

机译:苯达喹啉用于治疗耐多药结核和终末期肾脏疾病的患者:一例报告

获取原文
           

摘要

The use of bedaquiline to treat patients with multidrug-resistant tuberculosis (MDR-TB) and end-stage renal disease (ESRD) may raise safety concerns. Currently, no clinical information is available on the use of bedaquiline to treat MDR-TB patients with ESRD. We report the use of bedaquiline to treat two patients with MDR-TB and ESRD. This report highlights the safety and tolerability of bedaquiline as well as the treatment outcome. The use of bedaquiline in patients with ESRD is also discussed.
机译:使用苯达喹啉治疗耐多药结核病(MDR-TB)和终末期肾病(ESRD)的患者可能会引发安全问题。目前,尚无有关使用苯达喹啉治疗患有ESRD的耐多药结核病患者的临床信息。我们报告了使用苯达喹啉治疗两名耐多药结核病和ESRD的患者。该报告强调了苯达喹啉的安全性和耐受性以及治疗结果。还讨论了苯达喹啉在ESRD患者中的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号